Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

NCT05035238 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

OTHER_GOV

Sponsor class

Stopped the clinical trial did not initiated

Conditions

Covid19

Interventions

BIOLOGICAL: Triple dose vaccination by inactivated Covid19 vaccine

Sponsor

Health Institutes of Turkey

Collaborators

[object Object]
[object Object]